474
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

, , , , , , , , , , , , , , , & show all
Pages 3082-3089 | Received 14 Nov 2014, Accepted 21 Mar 2015, Published online: 12 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hiromichi Takahashi, Katsuhiro Miura, Masaru Nakagawa, Masahiko Sugitani, Yusuke Amano, Daisuke Kurita, Masashi Sakagami, Shimon Ohtake, Yoshihito Uchino, Hitomi Kodaira, Noriyoshi Iriyama, Sumiko Kobayashi, Atsuko Hojo, Yujin Kobayashi, Yukio Hirabayashi, Machiko Kusuda, Yoshihiro Hatta, Tomohiro Nakayama & Masami Takei. (2016) Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy. Leukemia & Lymphoma 57:12, pages 2784-2790.
Read now
Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Asami Izu, Masahiko Sugitani, Daisuke Kurita, Masashi Sakagami, Shimon Ohtake, Yoshihito Uchino, Atsuko Hojo, Hitomi Kodaira, Mai Yagi, Yujin Kobayashi, Noriyoshi Iriyama, Sumiko Kobayashi, Satomi Kiso, Yukio Hirabayashi, Yoshihiro Hatta & Masami Takei. (2016) Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy. Leukemia & Lymphoma 57:6, pages 1335-1341.
Read now
Marie José Kersten & Jeroen E. J. Guikema. (2015) MYC in diffuse large B-cell lymphoma: always the bad guy?. Leukemia & Lymphoma 56:11, pages 3003-3004.
Read now

Articles from other publishers (10)

Dongfeng Zeng, Aakash Desai, Fangfang Yan, Tiejun Gong, Haige Ye, Makhdum Ahmed, Krystle Nomie, Jorge Romaguera, Richard Champlin, Shaoying Li & Michael Wang. (2019) Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma). American Journal of Clinical Oncology 42:3, pages 304-316.
Crossref
Erika M. Moore, Nidhi Aggarwal, Urvashi Surti & Steven H. Swerdlow. (2017) Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid Morphology. American Journal of Surgical Pathology 41:9, pages 1155-1166.
Crossref
Pierre Sesques & Nathalie A. Johnson. (2017) Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements. Blood 129:3, pages 280-288.
Crossref
Alex F. HerreraMatthew MeiLawrence LowHaesook T. KimGabriel K. GriffinJoo Y. SongReid W. MerrymanVictoria BedellChristine PakHeather SunTanya ParisTracey StillerJennifer R. BrownLihua E. BuddeWing C. ChanRobert ChenMatthew S. DavidsArnold S. FreedmanDavid C. FisherEric D. JacobsenCaron A. JacobsonAnn S. LaCasceJoyce Murata-CollinsAuayporn P. NademaneeJoycelynne M. PalmerGerman A. PihanRaju PillaiLeslie PopplewellTanya SiddiqiAliyah R. SohaniJasmine ZainSteven T. RosenLarry W. KwakDavid M. WeinstockStephen J. FormanDennis D. WeisenburgerYoung KimScott J. RodigAmrita KrishnanPhilippe Armand. (2017) Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. Journal of Clinical Oncology 35:1, pages 24-31.
Crossref
Joo Y. Song & Dennis D. Weisenburger. 2017. Management of Lymphomas: A Case-Based Approach. Management of Lymphomas: A Case-Based Approach 33 44 .
Bertrand Coiffier & Clémentine Sarkozy. (2016) Diffuse large B-cell lymphoma: R-CHOP failure—what to do?. Hematology 2016:1, pages 366-378.
Crossref
Daniel J. Landsburg, Marissa K. Falkiewicz, Adam M. Petrich, Benjamin A. Chu, Amir Behdad, Shaoying Li, L. Jeffrey Medeiros, Ryan D. Cassaday, Nishitha M. Reddy, Martin A. Bast, Julie M. Vose, Kimberly R. Kruczek, Scott E. Smith, Priyank Patel, Francisco Hernandez-Ilizaliturri, Reem Karmali, Saurabh Rajguru, David T. Yang, Joseph J. Maly, Kristie A. Blum, Weiqiang Zhao, Charles Vanslambrouck & Chadi Nabhan. (2016) Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable . British Journal of Haematology 175:4, pages 631-640.
Crossref
Penelope Korkolopoulou, Theodoros Vassilakopoulos, Vassilios Milionis & Maria Ioannou. (2016) Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review. Advances in Anatomic Pathology 23:4, pages 202-243.
Crossref
Daniel J. Landsburg. (2016) Management of Patients with MYC-Altered Lymphomas. Current Hematologic Malignancy Reports 11:3, pages 208-217.
Crossref
J. Han van Krieken. (2015) New developments in the pathology of malignant lymphoma: a review of literature published from January 2015 to April 2015. Journal of Hematopathology 8:2, pages 71-79.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.